World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
https://doi.org/10.1142/9781786344946_0024Cited by:0 (Source: Crossref)
Abstract:

The following sections are included:

  • Assessment of haemorrhage should include classification of haemorrhage severity and checking blood parameters including full blood count (FBC), coagulation parameters, fibrinogen level, renal function and liver function tests.

  • Peri-operative management of haemorrhage includes activation of the major haemorrhage protocol, administration of oxygen and IV fluids and early surgical or endovascular intervention to stop the bleeding.

  • Acidosis and hypothermia are confounding factors which can exacerbate bleeding and should be addressed.

  • Targeted procoagulation interventions should be considered, which include administration of fibrinogen, cryoprecipitate, FFP and platelets.

  • Antifibrinolytic agents and recombinant factor VIIa can have a role.

  • Antidotes are now available for most of the antithrombotic drugs including the new oral anticoagulants (NOACs).

  • Post-operatively, antithrombotic therapy or venous thromboembolism (VTE) prophylaxis should be recommenced once haemostasis has been achieved.